Filter posts

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s …

BIO-Europe Spring Opening Remarks

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

Big Ventures

It is rare to see triple digit millions in private financing rounds, but it does …

It Takes a Village: The New Pharma-VC Model for Biotech Investing

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in …

BIO Europe Spring 2012 - Opening Remarks

For Monday’s Opening Remarks at BIO Europe Spring 2012, I covered the following topics: Public …

Venture Capital increases in 2011, but...

The National Venture Capital Association (NVCA) has released their 4Q 2011 numbers for biotech venture …

Multiple Assets Diversify the Deal

With a recent surge in pharma companies collaborating earlier on with small biotech companies, discovery …

Medical Innovation at Risk

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists …

Policies that Benefit Start-Ups Grow the Bio-Economy

The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain …